The FDA approved suzetrigine (Journavx, previously VX-548; Vertex Pharmaceuticals Incorporated) to treat moderate-to-severe acute pain. The…
Continue Reading
The FDA approved suzetrigine (Journavx, previously VX-548; Vertex Pharmaceuticals Incorporated) to treat moderate-to-severe acute pain. The…
Continue Reading